Malignant neoplasm of left optic nerve
ICD-10 C72.32 is a billable code used to indicate a diagnosis of malignant neoplasm of left optic nerve.
C72.32 refers to a malignant neoplasm located in the left optic nerve, which is a critical component of the central nervous system (CNS). This type of tumor can arise from glial cells, meningeal tissue, or other neural elements. Symptoms may include vision changes, headaches, and neurological deficits due to increased intracranial pressure or direct invasion of surrounding structures. Imaging studies, particularly MRI, are essential for diagnosis, allowing visualization of the tumor's size, location, and potential involvement of adjacent structures. Molecular markers, such as IDH mutations and 1p/19q co-deletion status, may provide prognostic information and guide treatment decisions. Treatment typically involves a multidisciplinary approach, including surgery, radiation therapy, and chemotherapy, depending on the tumor's characteristics and patient health. Neurological function assessment is crucial for monitoring the impact of the tumor and treatment on the patient's quality of life.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis and management of optic nerve tumors, treatment response evaluation.
Ensure accurate staging and grading of the tumor for appropriate coding.
Neurological assessments, imaging results, and symptomatology.
Evaluation of vision changes, headaches, and neurological deficits.
Document neurological function assessments to support diagnosis.
Used when a malignant neoplasm of the optic nerve is surgically removed.
Operative report detailing the procedure and findings.
Ensure coordination between oncology and neurosurgery for accurate coding.
MRI is the preferred imaging modality for diagnosing malignant neoplasms of the optic nerve, providing detailed information about the tumor's size, location, and involvement of surrounding structures.
